Tranquo-Tablinen
Brand names,
Tranquo-Tablinen
Analogs
Tranquo-Tablinen
Brand Names Mixture
Tranquo-Tablinen
Chemical_Formula
C16H13ClN2O
Tranquo-Tablinen
RX_link
http://www.rxlist.com/cgi/generic/diazepam.htm
Tranquo-Tablinen
fda sheet
Tranquo-Tablinen
msds (material safety sheet)
Tranquo-Tablinen
Synthesis Reference
Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)
Tranquo-Tablinen
Molecular Weight
284.74 g/mol
Tranquo-Tablinen
Melting Point
125-126oC
Tranquo-Tablinen
H2O Solubility
Slightly soluble (50 mg/L)
Tranquo-Tablinen
State
solid
Tranquo-Tablinen
LogP
2.988
Tranquo-Tablinen
Dosage Forms
Tablets; Injectable solution
Tranquo-Tablinen
Indication
Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.
Tranquo-Tablinen
Pharmacology
Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.
Tranquo-Tablinen
Absorption
Essentially complete, with a bioavailability of 93%.
Tranquo-Tablinen
side effects and Toxicity
Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.
Tranquo-Tablinen
Patient Information
Tranquo-Tablinen
Organisms Affected
Humans and other mammals